Global Blood Therapeutics (GBT) – Hot Corp. News
-
Pfizer (PFE) to Acquire Global Blood Therapeutics (GBT) for $5.4 Billion, $68.50 Per Share
-
Global Blood Therapeutics (GBT) and Syros Partner (SYRS) to Discover, Develop and Commercialize Novel Therapies for SCD and Beta Thalassemia
-
-
-
-
-
-
-
-
Back to GBT Stock Lookup